Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules. (2024)

First Author: Lamb KD

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pcbi.1011795

PubMed Identifier: 38271457

Publication URI: http://europepmc.org/abstract/MED/38271457

Type: Journal Article/Review

Volume: 20

Parent Publication: PLoS computational biology

Issue: 1

ISSN: 1553-734X